Kebuzone
| Clinical data | |
|---|---|
| Routes of administration | intramuscular |
| ATC code | |
| Pharmacokinetic data | |
| Elimination half-life | 70–100 hours |
| Excretion | renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.011.560 |
| Chemical and physical data | |
| Formula | C19H18N2O3 |
| Molar mass | 322.364 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Kebuzone (or ketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA).